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ATR/Chk1/Smurf1 pathway determines cell fate
after DNA damage by controlling RhoB abundance
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ATM- and RAD3-related (ATR)/Chk1 and ataxia–telangiectasia mutated (ATM)/Chk2
signalling pathways play critical roles in the DNA damage response. Here we report that the
E3 ubiquitin ligase Smurf1 determines cell apoptosis rates downstream of DNA damage-
induced ATR/Chk1 signalling by promoting degradation of RhoB, a small GTPase recognized
as tumour suppressor by promoting death of transformed cells. We show that Smurf1 targets
RhoB for degradation to control its abundance in the basal state. DNA damage caused by
ultraviolet light or the alkylating agent methyl methanesulphonate strongly activates Chk1,
leading to phosphorylation of Smurf1 that enhances its self-degradation, hence resulting in a
RhoB accumulation to promote apoptosis. Suppressing RhoB levels by overexpressing Smurf1
or blocking Chk1-dependent Smurf1 self-degradation significantly inhibits apoptosis. Hence,
our study unravels a novel ATR/Chk1/Smurf1/RhoB pathway that determines cell fate after
DNA damage, and raises the possibility that aberrant upregulation of Smurf1 promotes
tumorigenesis by excessively targeting RhoB for degradation.
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T
he ataxia–telangiectasia mutated (ATM) and ATM- and
RAD3-related (ATR) kinases are master regulators orches-
trating two distinct pathways, ATR/Chk1 and ATM/Chk2
signalling cascades in the DNA damage response. ATR/Chk1
signalling is usually activated by single-stranded DNA or bulky
DNA lesions, whereas ATM/Chk2 pathway is activated by DNA
double-strand breaks1,2. Despite the overlap between ATM- and
ATR-regulated signalling pathways, ATM knockout mice are
viable3, whereas ATR knockout leads to early embryonic lethality
at E7.5 due to chromosomal fragmentation-induced apoptosis,
presenting a critical role of ATR in maintaining genome
integrity4. Consistently, knockout of Chk1 leads to the
accumulation of DNA damage and apoptosis in ES cells,
resulting in embryonic lethality at E6.5 (ref. 5), but Chk2-null
mice appear normal6. In addition to maintaining the genome
integrity during DNA replication, cell cycle transition and DNA
repair, ATR/Chk1 signalling is also implicated in regulating
apoptosis. Moreover, ATR/Chk1 may mediate apoptosis from
different downstream pathways. For instance, Chk1
phosphorylates p73a, a p53-related transcription factor, to
induce apoptosis in response to severe DNA damage7. Chk1
can also phosphorylate Lats2, which results in p21 degradation
and leads to apoptosis8. Nevertheless, the underlying mechanism
for ATR/Chk1 signalling in regulating apoptosis remains to be
fully elucidated.
Smurf1 (Smad ubiquitination regulatory factor 1) belongs to
the HECT (homologous to the E6-AP carboxyl terminus) family
of E3 ubiquitin ligases. It was first identified as a negative
regulator of BMP (bone morphogenetic protein) signalling
pathway by selectively downregulating the BMP pathway-specific
Smad1 and Smad5 (ref. 9). Subsequent studies reveal that Smurf1
is also involved in regulating many other cellular activities,
including bone morphology, cell polarity and motility, cell
adhesion and TGFb (transforming growth factor b)-induced
epithelial-to-mesenchymal transition by targeting diverse
substrates such as RUNXs, MEKK2, Prickle1, TRAF4, Talin
head and small GTPase RhoA for ubiquitination10–17. Notably,
Smurf1 is found upregulated in colon cancer and pancreatic
cancer18–21, and its activity in mediating RhoA degradation is
essential for cancer cell invasive activity22–25, demonstrating a
pivotal role of Smurf1 in tumour progression.
As a major group of the Ras superfamily GTP-binding
proteins, the Rho family of small GTPases is recognized as key
regulators of actin cytoskeleton dynamics26,27. Moreover, the Rho
family small GTPases also regulate diverse cellular functions
including cell cycle, gene expression, vesicle trafficking and cell
polarity28,29. RhoA, RhoB and RhoC are 3 closely related Rho
GTPases that share 85% amino-acid sequence identity. However,
although RhoA, RhoB and RhoC all participate in inducing stress
fibre formation, they may exert very distinct roles in different
biological contexts30. In contrast to RhoA and RhoC that are
frequently overexpressed in various human tumours, RhoB levels
decrease in various types of cancer including lung cancer, gastric
cancer, ovary carcinoma and head and neck cancer31–35,
suggesting that RhoB suppresses tumorigenesis. Consistently,
overexpression of RhoB potently inhibits tumour growth in nude
mice36–38, whereas RhoB knockout in mice leads to increased
susceptibility to chemical-induced skin carcinogenesis39.
Mechanistic studies show that lack of RhoB significantly
attenuates DNA damage-induced apoptosis of transformed
cells40, and RhoB overexpression induces apoptosis in diverse
cancer cell lines41–46, indicating that RhoB may exerts its tumour
suppressor role through promoting cell apoptosis.
In this study, we identify Smurf1 as a downstream effector in
the ATR/Chk1 signalling pathway to determine the susceptibility
of DNA damage-caused apoptosis by regulating RhoB levels.
Activation of Chk1 after DNA damage mediates phosphorylation
of Smurf1 to promote its self-degradation, resulting in an
accumulation of RhoB to promote apoptosis. Excessive degrada-
tion of RhoB caused by upregulation of Smurf1 protects cancer
cells from DNA damage-induced apoptosis, suggesting that
Smurf1 is not only required for tumour metastasis by targeting
RhoA for degradation as previously reported12,16,25, but may also
be involved in tumour initiation by targeting RhoB for
degradation.
Results
RhoB is a substrate for E3 ubiquitin ligase Smurf1. Our pre-
vious study showed that E3 ubiquitin ligase Smurf1 plays a key
role in regulating cell polarity and protrusive activity through
targeting small GTPase RhoA for degradation13. We then
systematically investigated whether Smurf1 regulates other
members of Rho family proteins. Interestingly, although RhoB
and RhoC both share about 85% amino-acid sequence identity
with RhoA30, wild-type Smurf1, but not catalytically inactive
mutant Smurf1-C699A or its closest family member Smurf2,
selectively decreased steady-state levels of RhoB but not RhoC
(Fig. 1a). Meanwhile, overexpression of Smurf1 markedly
downregulated endogenous RhoB levels (Fig. 1b and
Supplementary Fig. 1a), whereas knockdown of Smurf1
significantly increased RhoB levels in both HeLa and HCT116
cells (Fig. 1c and Supplementary Fig. 1b).
To test whether RhoB is a substrate of Smurf1, we first
examined the interaction between Smurf1 and RhoB using
Smurf1-C699A, the catalytically inactive form of Smurf1, to trap
RhoB. Both endogenous and exogenous RhoB were found to
associate with Smurf1-C699A (Fig. 1d and Supplementary
Fig. 1c). In addition, in vitro glutathione S-transferase (GST)
pull-down assay using bacterially expressed proteins showed that
Smurf1 could directly bind RhoB (Fig. 1e). Next, we investigated
the effect of Smurf1 on RhoB ubiquitination. Overexpression of
wild-type Smurf1 but not Smurf1-C699A dramatically increased
RhoB ubiquitination in vivo (Fig. 1f). Consistently, knockdown of
Smurf1 significantly decreased the basal ubiquitination of RhoB
(Fig. 1g), suggesting that endogenous Smurf1 targets RhoB for
ubiquitination. We also performed in vitro ubiquitination assay
using bacterially expressed RhoB and GST/Smurf1, and found
that Smurf1 could directly catalyse ubiquitin conjugation of RhoB
(Fig. 1h), confirming that RhoB is a direct substrate of Smurf1.
Accordingly, co-expression of Smurf1 significantly decreased the
half-life of RhoB, whereas knockdown of Smurf1 prolonged its
half-life (Supplementary Fig. 1d).
C2 domain is critical for Smurf1-mediated RhoB degradation.
Smurf1 consists of a C2 domain, two WW domains and a HECT
domain, in which C2 domain is known as a phospholipid-binding
domain, WW domains are used to interact with substrates con-
taining PY motifs such as Smad1, and HECT is the E3 ligase
catalytic domain. Our previous study showed that the C2 domain
is critical for Smurf1 to bind RhoA47. Therefore, we examined the
role of C2 domain in the interaction between Smurf1 and RhoB.
Similar to RhoA, the C2 domain played an important role in
interacting with RhoB as well (Fig. 2a–c). As shown in Fig. 2b,
RhoB could associate with either full-length Smurf1 or Smurf1-
truncated mutants that contain C2 and/or HECT domain, but not
with Smurf1 mutant that only contains WW domains, in co-
immunoprecipitation (IP) assay. In addition, GST pull-down
assay using bacterially expressed proteins showed a strong
interaction between RhoB and the C2 domain, indicating that
the C2 domain of Smurf1 could directly bind RhoB (Fig. 2c).
Intriguingly, deletion of the C2 domain completely blocked
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Figure 1 | Smurf1 targets RhoB for ubiquitination and degradation. (a) Overexpression of Smurf1 decreases protein levels of RhoA, RhoB, but
not RhoC. HEK293T cells were transiently transfected with the indicated combinations of Flag-tagged RhoA (F/RhoA), RhoB (F/RhoB) or RhoC (F/RhoC)
and Flag-tagged Smurf1 (F/Smurf1) or Smurf2 (F/Smurf2), wild-type (WT) or catalytically inactive mutants Smurf1-C699A (C699A) or Smurf2-C716A
(C716A), respectively. Total cell lysates were subjected to immunoblotting (IB) to determine the protein levels. Levels of GAPDH were used as a loading
control. (b) Smurf1 overexpression decreases endogenous RhoB protein levels. HeLa cells transduced with control lentivirus or lentivirus encoding F/Smurf1
(WT or C699A) were subjected to immunoblotting. (c) Knockdown of Smurf1 increases endogenous RhoB protein levels. HeLa cells transduced with
lentivirus encoding control shRNA (sh-Con) or Smurf1 shRNA (sh-Smurf1-1 and sh-Smurf1-2) as indicated were subjected to immunoblotting. (d) Smurf1
interacts with endogenous RhoB proteins. Cell lysates from HeLa cells transduced with Flag-tagged Smurf1-C699A were subjected to anti-RhoB
immunoprecipitation (IP) followed by immunoblotting with mouse anti-Flag to detect associated Smurf1-C699A. (e) In vitro interaction between Smurf1
and RhoB. Bacterially expressed and purified RhoB protein and GST-tagged Smurf1 (GST/Smurf1) were subjected to GST pull-down assay as indicated.
Associated RhoB and GST/Smurf1 were detected by immunoblotting with appropriate antibodies. GST was detected by Ponceau S staining. (f) Smurf1
promotes ubiquitination of RhoB. HEK293T cells transfected with indicated combinations of F/RhoB, Myc-tagged Smurf1 (Myc/Smurf1) (WT or C699A)
and HA-tagged ubiquitin (HA/Ub) were treated with 10mM MG-132 overnight before subjected to anti-Flag IP, eluted by boiling in 1% SDS, and then
reprecipitated with anti-Flag antibody (2 IP). Ubiquitin-conjugated RhoB [(Ub)n-RhoB] was detected by immunoblotting with anti-HA antibody.
Expression of Myc/Smurf1, F/RhoB and HA/Ub were confirmed by immunoblotting the total cell lysates. (g) Knockdown of Smurf1 attenuates basal RhoB
ubiquitination. HEK293T cells transfected with indicated combinations of F/RhoB, HA/Ub and small hairpin RNAs against Smurf1 were subjected to
ubiquitination assay as described in f. (h) Smurf1 mediates ubiquitination of RhoB directly in vitro. RhoB and GST/Smurf1 (WT or C699A) purified from
bacteria were subjected to an in vitro ubiquitination assay. Ubiquitinated RhoB was detected with anti-Ub antibody.
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Smurf1-dependent exogenous and endogenous RhoB degradation
(Fig. 2d and Supplementary Fig. 2a), it however retained partial
activity towards mediating RhoB ubiquitination (Fig. 2e).
Previous studies showed that in addition to regulating typical
K48-linked ubiquitination, Smurf1 could also mediate
unconventional ubiquitination through non-K48-linkage48,49.
We therefore examined the chain linkage of ubiquitination of
RhoB by using ubiquitin mutants R48 (only Lys48 mutated to
Arg) and K48 (all Lys residues except Lys48 mutated to Arg).
Interestingly, wild-type Smurf1-mediated RhoB ubiquitination
using ubiquitin K48 mutant, whereas DC2 mutant and the HECT
domain alone mediated RhoB ubiquitination using ubiquitin R48
mutant (Supplementary Fig. 2b,c), suggesting that deletion of C2
domain may change the pattern of Smurf1-mediated RhoB
ubiquitination, likely owing to a conformational change of RhoB–
Smurf1 complex upon the deletion of C2 domain. Hence, our
results reveal a pivotal role of C2 domain in Smurf1-dependent
RhoB degradation.
Lys6 and Lys7 residues are the ubiquitination sites. We next
identified the ubiquitin-conjugating site of RhoB in Smurf1-
mediated ubiquitination. Since RhoA and RhoB are almost





























































































































































































Figure 2 | The C2 domain of Smurf1 directly interacts with RhoB and is required for Smurf1-mediated RhoB ubiquitination and degradation.
(a) Schematics of Smurf1 domains and truncated mutants. (b) Domain mapping for Smurf1 and RhoB interaction by co-immunoprecipitation assay. Cell
lysates form HEK293T cells transfected with indicated combinations of triple HA-tagged RhoB (3HA/RhoB) and Flag-tagged Smurf1 (F/Smurf1) or its
truncated mutants were subjected to anti-Flag IP followed by immunoblotting (IB) with rat anti-HA antibody to detect associated RhoB. (c) In vitro domain
mapping for Smurf1 and RhoB by GST pull-down assay. Bacterially expressed RhoB and GST-tagged Smurf1 (GST/Smurf1) or its truncated mutants
were subjected to GST pull-down assay. Associated RhoB was detected by western blot with anti-RhoB antibody. (d) The C2 domain is required for
Smurf1-mediated exogenous RhoB degradation. HEK293Tcells transfected with combinations of Flag-tagged RhoB (F/RhoB) and F/Smurf1 (WT or indicated
mutants) were subjected to immunoblotting. (e) Deletion of C2 domain attenuates Smurf1-mediated RhoB ubiquitination. HEK293T cells transfected
with combinations of F/RhoB, HA/Ub and Myc/Smurf1 (WT or indicated mutants) were subjected to ubiquitination assay. Ubiquitinated RhoB was
detected with anti-HA antibody.
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study showed that Smurf1 targets RhoA for ubiquitination on its
Lys6 and Lys7 residues12, we hypothesized that Smurf1 may
also catalyse the ubiquitin conjugation of RhoB on its Lys6 and
Lys7. Indeed, similar to RhoA-K6,7R mutant12, RhoB-K6,7R
was also resistant to Smurf1-induced degradation (Fig. 3b).
Consistently, the Smurf1-dependent ubiquitination of RhoB was
significantly attenuated by K6,7R mutation (Fig. 3c). Thus, our
data demonstrate that Smurf1 indeed targets RhoB for
ubiquitination at Lys6 and Lys7.
RhoB degradation is not necessary for protrusive activity. Since
Smurf1-regulated RhoA degradation is important for cell pro-
trusive activity13, we investigated whether Smurf1-mediated
RhoB degradation has the similar function. Same as previously
reported13, overexpression of wild-type Smurf1 but not Smurf1-
C699A resulted in a large number of long protrusions in Mv1Lu
epithelial cells (Fig. 4a). Interestingly, co-expression of RhoA-
K6,7R strongly blocked Smurf1 overexpression-induced long
protrusion formation, whereas co-expression of RhoB-K6,7R
showed a much weaker blocking effect (Fig. 4a,b). Moreover,
previous study showed that knockdown of Smurf1 causes
HEK293T cells to lose their protrusions13. Simultaneously
knockdown of RhoA but not RhoB rescued the cellular
protrusions in Smurf1 knocked-down cells (Fig. 4c). In
addition, overexpression of either RhoA-K6,7R or RhoB-K6,7R
did not affect Smurf1-mediated degradation of RhoA or RhoB,
indicating that the K6,7R mutant of RhoA or RhoB is not
functioning as a dominant-negative form of substrate
(Supplementary Fig. 3a–d). These results suggest that Smurf1
regulates protrusive activity through mediating RhoA but not
RhoB degradation.
Smurf1-mediated RhoB degradation inhibits apoptosis. It
has been reported that RhoB plays an important role in
DNA damage-induced apoptosis, and functions as a tumour
suppressor46. In agreement with previous reports, knockdown
of RhoB significantly decreased ultraviolet or methyl methane-
sulphonate (MMS)-induced apoptosis in HeLa cells (Fig. 5a and
Supplementary Fig. 4a,b). In addition, overexpression of either
wild-type RhoB or RhoB-K6,7R enhanced the apoptotic effects in
a dose-dependent manner (Fig. 5b and Supplementary Fig. 4c,d).
The protein levels of endogenous and exogenous RhoB were
validated by western blot (Supplementary Fig. 4e,f). We therefore
asked whether Smurf1-dependent RhoB degradation is involved
in regulating apoptosis in response to DNA damage. To test this
possibility, we first examined the levels of Smurf1 and RhoB in
HeLa cells in response to ultraviolet or MMS treatment.
Remarkably, Smurf1 protein levels significantly decreased after
lethal dose (80 J m 2) ultraviolet or MMS treatment, with a
corresponding increase of RhoB (Fig. 5c,d), whereas low-dose
(10 J m 2) ultraviolet radiation, which did not induce significant
levels of apoptosis in HeLa cells, did not change the protein levels
of Smurf1 and RhoB (Fig. 5c). The downregulation of Smurf1 and
correlated increase of RhoB in response to ultraviolet or MMS
treatment could also be observed in various other cell lines
including human colon cancer HCT116, human hepatocellular
carcinoma HepG2, human non-small lung cancer A549 and
human breast cancer MCF-7 cells (Supplementary Fig. 5a,b),
suggesting that changes of Smurf1 and RhoB protein levels may
be correlated with apoptosis. However, treatment of cisplatin or
doxorubicin (Dox), two other commonly used DNA-damaging
agents, did not affect either Smurf1 or RhoB protein levels
(Supplementary Fig. 5c,d).
Interestingly, the ultraviolet or MMS treatment-caused
decrease of Smurf1 was not due to downregulation of its
messenger RNA (mRNA) levels (Supplementary Fig. 6a). In
agreement with previous reports that transcription of RhoB can
be quickly induced by DNA-damaging stresses50,51, we observed
that RhoB mRNA levels increased to 1.5-fold after ultraviolet or
MMS treatment (Supplementary Fig. 6b). Nevertheless, it is



























































Figure 3 | Smurf1 mediates RhoB ubiquitination at its Lysines 6 and 7. (a) Amino-acid sequence alignment of RhoA and RhoB. Lys6 and Lys7 are
indicated with asterisks. (b) Lysines 6 and 7 of RhoB are necessary for Smurf1-mediated RhoB degradation. HEK293T cells were transiently transfected with
F/Smurf1 (WT or C699A) and Flag-tagged RhoB (F/RhoB) or RhoB-K6,7R mutant (F/RhoB-K6,7R). Steady-state protein levels were determined by
immunoblotting. (c) Smurf1 targets RhoB ubiquitination at Lys6 and Lys7. HEK293T cells transfected with indicated combinations of HA/Ub, Myc/Smurf1
and Flag/RhoB or F/RhoB-K6,7R were subjected to ubiquitination assay. Ubiquitin-conjugated RhoB [(Ub)n-RhoB] was detected by immunoblotting
with anti-HA antibody.
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protein levels. Hence, we tested whether attenuation of the
Smurf1-mediated RhoB degradation is required for the
upregulation of RhoB induced by ultraviolet or MMS. Indeed,
exogenous expression of Smurf1 significantly inhibited the
increase of RhoB in ultraviolet or MMS-treated cells (Fig. 5e
and Supplementary Fig. 6c). We further validated the
contribution of stabilization of RhoB in its upregulation by
blocking protein translation or gene transcription using
cycloheximide or actinomycin, respectively. Indeed, the protein
levels of RhoB in cells treated with ultraviolet or MMS were
significantly higher than that in cells without ultraviolet or MMS
treatment even when protein translation or gene transcription
had been blocked (Fig. 5f and Supplementary Fig. 6d–f).
Moreover, treatment of ultraviolet or MMS significantly
attenuated basal ubiquitination of RhoB and increased its half-
life (Fig. 5g, Supplementary Fig. 6g,h), confirming that increasing
the protein stability of RhoB plays a key role in upregulation of
RhoB in response to ultraviolet or MMS treatment.
Next, we examined the roles of Smurf1 in regulating ultraviolet
or MMS-triggered apoptosis. As expected, overexpression of wild-
type Smurf1 but not Smurf1-C699A significantly reduced
apoptotic rates of HeLa cells after ultraviolet radiation or MMS
treatment (Fig. 5h and Supplementary Fig. 7a,b). To determine
whether reduced apoptosis caused by Smurf1 overexpression is
through enhancing RhoB degradation, we co-expressed RhoB-
K6,7R to do the rescue experiments. Indeed, co-expression of
RhoB-K6,7R rescued the ultraviolet or MMS treatment-induced
apoptosis in a dose-dependent manner, whereas co-expression of
RhoA-K6,7R had no rescue effect (Fig. 5h and Supplementary
Fig. 7a,b). Meanwhile, knockdown of Smurf1 markedly enhanced
ultraviolet or MMS treatment-induced apoptosis, and simulta-
















































































































Figure 4 | Smurf1-mediated RhoB degradation is dispensable for regulation of cell protrusive activity. (a,b) RhoA-K6,7R but not RhoB-K6,7R
blocks Smurf1-induced long protrusion formation. Mv1Lu cells were transfected with HA-tagged Smurf1 (HA/Smurf1), wild-type (WT) or catalytically
inactive mutant (C699A), with or without Flag-tagged RhoA-K6,7R (F/RhoA-K6,7R) or RhoB-K6,7R (F/RhoB-K6,7R) as indicated. The cells were
subjected to immunofluorescence assay with appropriate antibodies to examine the protein expression 24 h after transfection and Texas red conjugated
Phalloidin was used to visualize F-actin (a). The scale bars indicate 5 mm. The percentage of Mv1Lu cells with long protrusions were quantified and plotted
in b. A minimum of 100 cells were scored for each experiment and data are represented as mean±s.d. of three independent experiments. Data are
assessed by one-way analysis of variance and Tukey’s HSD post test after arcsine transformation. ***Po0.001. (c) Knockdown of RhoA but not RhoB
rescues the morphological change and actin cytoskeleton rearrangements caused by reducing Smurf1 levels. HEK293T cells were transfected with indicated
combinations of small hairpin RNAs against Smurf1 (sh-Smurf1-1), RhoA (sh-RhoA) or RhoB (sh-RhoB-1) as indicated. The cells were visualized
48 h later by phase contrast microscopy (top) or Texas red-phalloidin staining (bottom). The scale bars indicate 20mm.
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Figure 5 | Smurf1 inhibits ultraviolet or MMS-induced apoptosis through downregulating RhoB. (a) RhoB is required for ultraviolet or MMS-induced
apoptosis. HeLa cells transduced with lentivirus encoding indicated small hairpin RNAs were subjected to flow cytometry assay 24 h after 80 J m 2
ultraviolet or 0.5 mM MMS treatment. Data of three independent experiments were assessed by one-way analysis of variance and Tukey’s HSD post test
after arcsine transformation and represented as mean±s.d. ***Po0.001. (b) RhoB dose dependently enhances ultraviolet or MMS-induced apoptosis.
HeLa cells with overexpression of F/RhoB or F/RhoA (WT or K6,7R) were treated and analysed same as in a. Data assessment is same as in a. ***Po0.001.
(c,d) Lethal dose of ultraviolet or MMS treatment upregulates RhoB levels and downregulates Smurf1 levels. HeLa cells were lysed at indicated time points
after treatment of ultraviolet (80 or 10 J m 2) (c) or 0.5 mM MMS (d) before subjected to immunoblotting. (e) Overexpression of Smurf1 attenuates
ultraviolet-induced RhoB upregulation. HeLa cells with overexpression of F/Smurf1 (WT or C699A) were subjected to immunoblotting 4 h after irradiated
with 80 J m 2 ultraviolet. (f) Ultraviolet or MMS treatment stabilizes RhoB. HeLa cells pretreated with or without cycloheximide (CHX, 3.5 mM) 0.5 h
before treated with ultraviolet (80 J m 2) or MMS (0.5 mM) were lysed 4 h later and subjected to immunoblotting. (g) Ultraviolet or MMS treatment
attenuates endogenous RhoB ubiquitination. HeLa cells transduced with lentivirus encoding HA/Ub were lysed 6 h after ultraviolet or MMS treatment
before subjected to immunoprecipitation with anti-HA antibody. Ubiquitinated RhoB was detected with anti-RhoB antibody. (h) Smurf1 suppresses
ultraviolet or MMS-induced apoptosis via downregulating RhoB. HeLa cells with overexpression of indicated combination of F/Smurf1 (WT or C699A),
F/RhoA-K6,7R or F/RhoB-K6,7R were treated and analysed same as in a. Data assessment is same as in a. ***Po0.001. (i) Simultaneously knocking
down RhoB suppresses Smurf1 knockdown-enhanced apoptosis. HeLa cells transduced with lentivirus encoding indicated small hairpin RNAs were treated
same as in a before subjected to flow cytometry assay. Data were assessed same as in a. ***Po0.001.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5901 ARTICLE
NATURE COMMUNICATIONS | 5:4901 | DOI: 10.1038/ncomms5901 | www.nature.com/naturecommunications 7
& 2014 Macmillan Publishers Limited. All rights reserved.
decreased the apoptotic rates upregulated by Smurf1 knockdown
(Fig. 5i and Supplementary Fig. 7c,d). The corresponding levels of
RhoB were validated by immunoblotting (IB) (Supplementary
Fig. 8a-c). These results demonstrate that Smurf1 regulates the
apoptotic susceptibility to ultraviolet or MMS-induced DNA
damage via controlling RhoB protein levels.
ATR/Chk1 signalling promotes Smurf1 autodegradation. We
next investigated the mechanism by which Smurf1 is down-
regulated in response to DNA damage. Since the downregulation
of Smurf1 caused by ultraviolet or MMS treatment was not due to
the decrease of its mRNA levels (Supplementary Fig. 6a), we
examined whether it is through protein degradation. Indeed, the
proteasome inhibitor MG-132 could effectively protect Smurf1
from ultraviolet or MMS-induced downregulation (Fig. 6a),
indicating that the decrease of Smurf1 after ultraviolet or MMS
treatment is via proteasome-dependent degradation pathway. As
previous report showed that Smurf1 could target itself for ubi-
quitination52, we further tested whether the decrease of Smurf1 is
through self-degradation. Remarkably, wild-type Smurf1 but not
Smurf1-C699A mutant was decreased after ultraviolet or MMS
treatment (Fig. 6b,c), indicating that the ultraviolet or MMS
treatment-induced downregulation of Smurf1 is dependent on its
E3 ligase catalytic activity. Correspondingly, ultraviolet or MMS
treatment drastically enhanced ubiquitination of wild-type
Smurf1 but not catalytic inactive mutant Smurf1-C699A
(Fig. 6d), confirming that downregulation of Smurf1 caused by
ultraviolet or MMS is through enhancing its self-ubiquitination.
Since protein kinases ATM and ATR (ATM and Rad3 related)
are master regulators of DNA damage response1, we detected
whether ATM/ATR signalling is required for Smurf1
downregulation in response to DNA damage. Strikingly, ATM/
ATR inhibitor caffeine significantly blocked the decrease of
Smurf1 and the corresponding increase of RhoB caused by
ultraviolet or MMS treatment (Fig. 7a and Supplementary
Fig. 9a), suggesting that ATM/ATR signalling is involved in
regulating the stability of Smurf1. Further examination using
small hairpin RNAs to specifically knock down ATM or ATR
indicated that ATR but not ATM is the upstream regulator for
Smurf1 downregulation (Fig. 7b and Supplementary Fig. 9b).
Since the checkpoint kinase 1 (Chk1) and checkpoint kinase 2
(Chk2) are key downstream kinases of ATM/ATR signalling in
DNA damage response1,2, we next investigated whether Chk1
and/or Chk2 are required for promoting Smurf1 self-degradation.
Significantly, treatment of Chk1 inhibitor but not Chk2 inhibitor
effectively blocked ultraviolet or MMS-caused decrease of Smurf1
and increase of RhoB (Fig. 7c and Supplementary Fig. 9c). We
further confirmed that it is Chk1 but not Chk2 responsible for
downregulating Smurf1 in response to DNA damage by
specifically knocking down Chk1 or Chk2 (Fig. 7d,e and
Supplementary Fig. 9d,e). Furthermore, overexpression of
Chk1-D130A, a dominant-negative form of Chk1, strongly
inhibited the downregulation of Smurf1 and upregulation of
RhoB caused by ultraviolet or MMS treatment (Fig. 7f and
Supplementary Fig. 9f), which further confirmed that the activity
of Chk1 is necessary to promote Smurf1 self-degradation. The
efficiency of cells expressing Chk1-D130A was confirmed by
immunofluorescence assay (Supplementary Fig. 9g). Moreover,
the necessity of Chk1 activity in downregulating Smurf1 levels
after ultraviolet or MMS treatment was also confirmed in
HCT116 colorectal cancer cells (Supplementary Fig. 10a-e and
Supplementary Fig. 11a–e). Interestingly, we examined the
phosphorylation of Chk1 and Chk2 and found that treatment
of ultraviolet or MMS strongly activated Chk1, whereas cisplatin
or Dox treatment potently activated Chk2 but not Chk1
(Supplementary Fig. 12a,b). It is noteworthy that Smurf1 is
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Figure 6 | Ultraviolet or MMS treatment promotes Smurf1 auto-ubiquitination and self-degradation. (a) Ultraviolet or MMS treatment downregulates
Smurf1 through proteasome pathway. HeLa cells were pretreated with or without MG-132 (20 mM) 2 h before treated with ultraviolet (80 J m 2)
or MMS (0.5 mM). The cells were then lysed 4 h after ultraviolet irradiation or MMS treatment and subjected to immunoblotting assay. (b) Ultraviolet
irradiation-induced Smurf1 downregulation is dependent on its E3 ligase activity. HeLa cells transduced with lentivirus encoding Flag-tagged Smurf1
(WT or C699A) were treated with 80 J m 2 ultraviolet lysed at indicated time points after ultraviolet irradiation, and then subjected to western blot assay.
GFP and GAPDH levels were used as transfection and loading controls, respectively. (c) MMS treatment-induced Smurf1 downregulation is dependent
on its E3 ligase activity. Same as in b except cells were treated with MMS (0.5 mM) instead of ultraviolet irradiation. (d) Ultraviolet irradiation or
MMS treatment promotes Smurf1 auto-ubiquitination. HEK293T cells transfected with Flag-tagged Smurf1 (WT or C699A) together with HA-tagged
ubiquitin (HA/Ub) as indicated were subjected to ubiquitination assay. Ubiquitin-conjugated Smurf1 [(Ub)n-Smurf1] was detected by immunoblotting with
anti-HA antibody.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5901
8 NATURE COMMUNICATIONS | 5:4901 | DOI: 10.1038/ncomms5901 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
frequently activated in cancer cells, however, the levels of
activated chk1 in cancer cells are dramatically lower than that
in cells after ultraviolet or MMS treatment (Supplementary
Fig. 12c,d), suggesting that a higher kinase activity level of Chk1
are required for promoting Smurf1 self-degradation.
Chk1 phosphorylates Smurf1 in response to DNA damage. To
investigate whether Smurf1 is a substrate of Chk1, we first
examined the interaction between Chk1 and Smurf1. Endogenous
Smurf1 was able to co-immunoprecipitate with Chk1 (Fig. 8a),
and the interaction between Smurf1 and Chk1 was significantly
enhanced by ultraviolet or MMS treatment (Fig. 8b). Remarkably,
neither binding of Smurf1 to Chk2 nor binding of Smurf2 to
Chk1 could be detected, indicating that Smurf1 specifically
interacted with Chk1 (Fig. 8c). We next examined the location
where Chk1 binds Smurf1 by subcellular fractionation assay.
Smurf1 is located in both nucleus and cytoplasm, whereas Chk1 is
mainly in nucleus and RhoB is in cytosol (Supplementary
Fig. 13a), and Smurf1 interacts with Chk1 in nucleus
(Supplementary Fig. 13b). Ultraviolet or MMS treatment induces
downregulation of Smurf1 in both nucleus and cytosol
(Supplementary Fig. 13a), indicating that although Chk1-induced
Smurf1 auto-ubiquitination might mainly occur in nucleus, it
drains the pool of Smurf1. Furthermore, we performed GST pull-
down assay using bacterially expressed proteins and found that
Chk1 could directly interact with Smurf1 in vitro (Fig. 8d).
Next, we carried out in vitro phosphorylation assay to examine
whether Chk1 can phosphorylate Smurf1. Strikingly, strong
phosphorylation of threonine residue(s) in Smurf1 was observed
by using a phospho-Thr specific antibody when GST/Smurf1 was
incubated with wild-type Chk1 but not Chk1-D130A in the
in vitro reaction, whereas no significant phosphorylation of
serine residue in Smurf1 could be detected (Fig. 8e). Using
matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF-MS), we identified that Thr145,
Thr161 and Thr682 of Smurf1 could be phosphorylated by
Chk1 (Supplementary Fig. 14). We next used Smurf1-3A, a
mutant with Thr145, Thr161 and Thr682 mutated to alanines, to
perform the in vitro phosphorylation assay. As expected, point
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Figure 7 | Ultraviolet irradiation promotes Smurf1 self-degradation through activating ATR/Chk1 signalling pathway. (a) Inactivation of ATM/ATR
prevents Smurf1 downregulation and RhoB upregulation after ultraviolet irradiation. HeLa cells were pretreated with or without caffeine (3 mM)
for 1 h before irradiated with 80 J m 2 ultraviolet. Endogenous levels of Smurf1 and RhoB at indicated time points after ultraviolet irradiation were examined
by immunoblotting. (b) Knockdown of ATR dampened Smurf1 downregulation and RhoB upregulation after ultraviolet irradiation. HeLa cells transduced
with lentivirus encoding control shRNA or small hairpin RNAs (shRNAs) against ATR or ATM were lysed at indicated time points after ultraviolet irradiation
and subjected to immunoblotting. (c) Chk1 activity is required for ultraviolet-induced Smurf1 downregulation and RhoB upregulation. HeLa cells were
pretreated with or without Chk1 inhibitor UCN-01 (Chk1 inh, 0.1 mM) or Chk2 inhibitor-II (Chk2 inh, 5 mM) for 1 h before irradiated with 80 J m 2
ultraviolet. Cells were then lysed at indicated time points after ultraviolet treatment and subjected to immunoblotting assay. (d,e) Knockdown of Chk1 but
not Chk2 inhibits ultraviolet-induced Smurf1 downregulation and RhoB upregulation. HeLa cells transduced with lentivirus encoding control shRNA or
shRNAs against Chk1 (d) or Chk2 (e) were lysed at indicated time points after 80 J m 2 ultraviolet irradiation, and then subjected to immunoblotting
assay. (f) Overexpression of dominant-negative form of Chk1 blocks ultraviolet-induced Smurf1 downregulation and RhoB upregulation. HeLa cells
transduced with control lentivirus or lentivirus encoding Flag-tagged kinase-dead mutant Chk1-D130A (F/Chk1-D130A) were irradiated with ultraviolet
(80 J m 2), lysed at indicated time points after the irradiation, and then subjected to immunoblotting.
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mutations of these three threonine residues to alanine totally
abolished the Chk1-mediated phosphorylation of Smurf1
(Fig. 8f), confirming that the phosphorylation sites for Chk1 in
Smurf1 are at Thr145, Thr161 and Thr682.
To verify these phosphorylation sites in cells, we immuno-
precipitated Flag-tagged Smurf1-C699A from cells treated with
or without ultraviolet or MMS and then subjected it to mass













































































































































































































































































Figure 8 | Chk1 promotes Smurf1 self-degradation by phosphorylating Smurf1. (a) Chk1 interacts with endogenous Smurf1. HeLa cells transduced
with control lentivirus or lentivirus encoding triple Flag-tagged Chk1 (3F/Chk1) were subjected to co-immunoprecipitation assay to detect associated
Smurf1. (b) Ultraviolet or MMS treatment enhances the interaction between Smurf1 and Chk1. HeLa cells transduced with lentivirus encoding F/Smurf1-
C699A and 3HA-tagged (3HA/Chk1) as indicated were treated with ultraviolet (80 J m 2) or MMS (0.5 mM), and subjected to co-IP assay 30 min
later to detect associated Chk1. (c) Chk1 but not Chk2 specifically interacts with Smurf1. HEK293T cells transfected with indicated combinations of
F/Smurf1-C699A, F/Smurf2-C716A, 3HA/Chk1, and 3HA/Chk2 were subjected to co-IP assay. (d) In vitro interaction between Chk1 and Smurf1. Chk1
and GST/Smurf1 purified from bacteria were subjected to GST pull-down assay. Associated Chk1 was determined by immunoblotting with anti-Chk1
antibody. GST/Smurf1 and GST were detected by Ponceau S staining. (e) Chk1 phosphorylates Smurf1 at its threonine residues. In vitro kinase assay was
carried out by incubating GST/Smurf1 with 3HA/Chk1 immunoprecipitated from MMS (0.5 mM, 2 h) treated HeLa cells. Phosphorylation of Smurf1 was
detected by immunoblotting using phosphothreonine or phospho-serine antibodies. (f) Chk1 phosphorylates Smurf1 at Thr145, Thr161 and Thr682.
GST/Smurf1, WT or T145,161,682A mutant (3A), were used to perform in vitro kinase assay same as in e. (g,h) Phosphorylation of Smurf1 by Chk1 is
necessary for ultraviolet or MMS-induced down-regulation of Smurf1. HeLa cells transduced with control lentivirus or lentivirus encoding F/Smurf1 (WT, 3A
or C699A) were subjected to immunoblotting at indicated time points after treated with 80 J m 2 ultraviolet (g) or 0.5 mM MMS (h). (i) Smurf1-3A
has more potent effect on suppressing ultraviolet or MMS-induced apoptosis. HeLa cells transduced with control lentivirus or lentivirus encoding F/Smurf1
(WT, 3A or C699A) were treated with 80 J m 2 ultraviolet or 0.5 mM MMS and then subjected to flow cytometry assay 32 h after the treatment.
Data of three independent experiments were assessed by one-way analysis of variance and Tukey’s HSD post test after arcsine transformation and
represented as mean±s.d. **Po0.01, ***Po0.001.
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Thr145, Thr161 and Thr682, could be phosphorylated after
ultraviolet or MMS treatment (Supplementary Fig. 15a,b),
whereas no phosphorylation of these sites could be detected in
cells without treatment. We next assessed the role of Chk1-
mediated phosphorylation in ATR/Chk1 signalling-induced
Smurf1 downregulation by examining the changes of Smurf1-
3A protein levels in response to ultraviolet and MMS treatment.
Remarkably, the 3A mutation significantly blocked the decrease
of Smurf1 and the corresponding increase of RhoB induced by
ultraviolet and MMS in both HeLa and HCT116 cells (Fig. 8g,h
and Supplementary Fig. 16a,b). Accordingly, Smurf1-3A showed
a more prominent effect on attenuating the apoptosis caused by
ultraviolet and MMS than wild-type Smurf1 (Fig. 8i and Supple-
mentary Fig. 16c). In addition, we confirmed that the Smurf1-3A
has the same activity to target RhoB for degradation (Supple-
mentary Fig. 16d). Taken together, our results demonstrated a
novel ATR/Chk1/Smurf1 signalling pathway in determining cell
fate after DNA damage by mediating RhoB abundance.
Discussion
ATR/Chk1 signalling pathway controls a wide range of cellular
responses to DNA damage from cell cycle arrest, DNA repair, to
apoptosis. The underlying mechanism for ATR/Chk1-regulated
apoptosis in the DNA damage response still remains unclear53. In
this study, we defined a novel pathway in which activation of
ATR/Chk1 signalling after DNA damage promotes Smurf1 self-
degradation by inducing its phosphorylation, thereby releases
RhoB from the control of Smurf1 to promote apoptosis,
providing another piece of the clue to elucidate the signalling
network of ATR/Chk1 in regulation of apoptosis under DNA
damage stress. Interestingly, cisplatin and Dox have less potency
to activate Chk1 compared with ultraviolet and MMS, although
they could effectively activate Chk2 (Supplementary Fig. 12);
therefore, treatment of cisplatin or Dox did not affect either
Smurf1 or RhoB protein levels (Supplementary Fig. 5c,d), which
is in good agreement with our finding that Smurf1 specifically
interacts with Chk1 but not Chk2 and self-degradation of Smurf1
promoted by Chk1 after ultraviolet or MMS treatment is
necessary for the upregulation of RhoB. Thus, our results
demonstrated that Smurf1 is a downstream effector specific for
ATR/Chk1 signalling in the DNA damage response.
Unlike RhoA and RhoC that are relatively stable, RhoB is a
short-lived protein with half-life of 2.5 h (ref. 54), and its levels
can be quickly and transiently upregulated by various growth and
stress stimuli including DNA damage46,51,55–57. However, the
identity of the responsible E3 ubiquitin ligase(s) for RhoB
turnover had been elusive. Our study, for the first time, identified
Smurf1 as an E3 ubiquitin ligase responsible for RhoB
degradation. We demonstrate here that Smurf1 plays a pivotal
role in controlling RhoB abundance, which might be necessary
for normal cell growth in the basal state, and ensure a prompt
response to apoptosis stimuli by quickly upregulating RhoB
through shutting down the Smurf1-mediated RhoB degradation.
Of note, Smurf1 may have multifaceted functions in regulating
apoptosis. Previous study showed that Smurf1 and Smurf2
promote p53 degradation by stabilizing MDM2, an E3 ligase for
p53, therefore inhibit apoptosis58. Our recent study presented
that under cAMP/PKA signalling, Smurf1 targets orphan nuclear
receptor Nur77 for atypical ubiquitination, therefore prevents its
degradation, which is required for cisplatin-induced apoptosis49.
Together with the Smurf1-mediated RhoB degradation in the
regulation of apoptosis, these studies suggest that Smurf1 may
exert distinct roles in mediating apoptosis under different
circumstances; however, the underlying mechanism remains to
be fully understood.
It is well established that defects in apoptosis may lead to
tumorigenesis59. Interestingly, recent studies showed that Smurf1
is frequently overexpressed in various types of human cancers
including colorectal and pancreatic cancers and act as a
protooncoprotein18–20,60. Previous studies showed that Smurf1-
mediated RhoA degradation is essential for TGFb-induced
epithelial-to-mesenchymal transition and cancer cell invasive
activity12,13,25, and Smurf1 could monoubiquitinate TRAF4 to
promote breast cancer cell migration16, indicating that Smurf1 is
required for tumour malignancy. Nevertheless, the fundamental
role of Smurf1 in tumorigenesis still remains largely unknown. It
is noteworthy that RhoB is recognized as a tumour suppressor by
virtue of its specific capability to induce apoptosis of transformed
cells46, and loss of RhoB is found in various types of cancer31–35.
Our study demonstrates a pivotal role of Smurf1 in favoring cell
survival under certain DNA damage, suggesting that Smurf1 may
function as an oncoprotein by excessively suppressing RhoB
protein levels in tumour initiation as well. It would be of great
interest to further explore the role of Smurf1-mediated RhoB
degradation in tumorigenesis, which may provide us new insights
into tumour development and potential strategy for cancer
therapy.
Methods
DNA constructs. Human Smurf1 (wild-type, C699A and truncated mutants),
Smurf2 (wild-type and C716A) and RhoA (wild-type and K6,7R mutant) have been
previously described12,13,47. Human RhoB and RhoC were cloned from HEK293T
cells using reverse transcription PCR. Human Chk1 and Chk2 were generous gifts
from Dr S.C. Lin. RhoB-K6,7R mutant, kinase-dead Chk1-D130A mutant and non-
phospho-mimicking mutant Smurf1-3A (Thr145A, Thr161A and Thr682A) were
generated by PCR-based site-directed mutagenesis. Expression plasmids for various
proteins were constructed into a modified pCMV5 vector for transfection or
pBOBI vector for lentivirus infection.
For gene silencing, the lentivirus-based vector pLL3.7 was used for expression of
shRNA. The sequences used for Smurf1 shRNA-1 and -2 are 50-GGTTACACCA
CATCATGAA-30 and 50-TGAAGGAACGGTGTATGAA-30 , respectively; for
RhoB shRNA-1 and -2 are 50-CCATCATCCTGGTGGCCAA-30 and 50-GCAAG
ACGTGCCTGCTGAT-30 , respectively; for RhoA shRNA is 50-AAGGCAGAGAT
ATGGCAAACA-30 ; for ATM and ATR shRNA are 50- GAAGGAAGCCAGAG
TACAA-30 and 50-GGTCAGCTGTCTACTGTTA-30, respectively; for Chk1
shRNA-1 and -2 are 50-GCGTGCCGTAGACTGTCCA-30 and 50-AAGGGATAA
CCTCAAAATCTC-30 , respectively; for Chk2 shRNA-1 and -2 are 50-GCCTTAA
GACACCCGTGGC-30 and 50-GAGGACTGTCTTATAAAGATT-30, respectively.
The scramble sequence 50-TTCTCCGAACGTGGCACGA-30 was used for a
control shRNA.
Antibodies and chemical reagents. Mouse anti-HA (sc-7392, 1:2,000), anti-Myc
(sc-40, 1:2,000), anti-GFP (sc-9996, 1:2,000), anti-Ub (sc-8017, 1:1,000), anti-GST
(sc-138,:2,000), anti-RhoA (sc-418, 1:2,000), anti-RhoB (sc-8048, 1:2,000), anti-
GAPDH (sc-32233, 1:2,000), rabbit anti-RhoB (sc-180, 1:1,000) antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA); mouse anti-
FLAG M2 (1:2,000) antibody was purchased from Sigma; rabbit anti-Chk1 (#2345,
1:1,000), anti-Chk2 (#2662, 1:1,000), anti-Phospho-Chk1 (ser345, #2348, 1:1,000),
anti-Phospho-Chk2 (Thr68, #2661, 1:1,000), anti-Phospho-Threonine (#9381,
1:1,000) antibodies were purchased from Cell Signaling Technology; rabbit anti-
Phospho-serine (61-8100, 1:1,000) antibody was purchased from Invitrogen
(Grand Island, NY, USA); mouse anti-Smurf1 (ab57573, 1:1,000), rabbit anti-
Smurf2 (ab53316, 1:1,000) antibodies were purchased from Abcam; rabbit anti-
ATM (PC116, 1:500), anti-ATR (PC538, 1:1,000) antibodies were purchased from
Calbiochem; rat anti-HA monoclonal (1:2,000) antibody was purchased from
Roche (Mannheim, Germany). Inhibitors for Chk1 (UCN-01, #539644) and Chk2
(Chk2 inhibitor-II #220486) were purchased from Calbiochem; proteasome inhi-
bitor MG-132 was from Boston Biochem (Cambridge, MA, USA); chloroquine,
MMS, Dox, cisplatin, actinomycin D, cycloheximide and Caffeine were from Sigma
(St Louis, MO, USA).
Cell culture and transfection. Human embryonic kidney HEK293T, human
cervical cancer HeLa, mink lung epithelial Mv1Lu, human breast cancer MCF-7,
human lung adenocarcinoma A549, human hepatocellular carcinoma HepG2,
mouse fibroblast NIH3T3 and mouse embryonic fibroblast cells were cultured
in high-glucose Dulbecco’s modified Eagle’s medium, human colorectal carcinoma
HCT116, human colon cancer SW480, human colon cancer HT-29 and human
osteosarcoma U2OS cells were cultured in McCoy’s 5A medium, all supplemented
with 10% (v/v) fetal calf serum (Gibco) and 100 units ml 1 streptomycin and
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penicillin (Millipore, Billerica, MA, USA), at 37 C in a humidified 5% CO2
incubator. HEK293T, HeLa, A549, U2OS, HepG2, Mv1Lu, SW480 and NIH3T3
cells were obtained from ATCC. HCT116, HT-29 and MCF-7 cells were purchased
from the Cell Bank of the Chinese Academy of Sciences (Shanghai). Mouse
embryonic fibroblast cells were a kind gift from Dr J Han.
HEK293T cells were transiently transfected using a calcium–phosphate method
as previously described61. Mv1Lu cells were transiently transfected with
Lipofectamine 2000 (Invitrogen) following the manufacturer’s protocol.
Recombinant lentivirus was generated using the ViraPower Lentiviral Expression
System (Invitrogen) for infecting HeLa and HCT116 cells.
IP and IB assays. IP and IB assays were performed as previously described61.
Briefly, cells were lysed on ice with lysis buffer TNTE 0.5% (50 mM Tris–HCl, pH
7.5, 150 mM NaCl, 1 mM EDTA and 0.5% Triton X-100, containing 10 mg ml 1
pepstatin A, 10mg ml 1 leupeptin and 1 mM PMSF). The cell lysates were applied
to IP or IB assays with appropriate antibodies. All the uncropped scans of the most
important immunoblots are included in Supplementary Figs 17–21.
Ubiquitination and GST pull-down assays. Ubiquitination and GST pull-down
assays were also performed as previously described61. For in vivo ubiquitination
assay, cell lysates were subjected to anti-Flag IP, eluted by boiling 5 min in 1% SDS,
diluted 10 times in lysis buffer TNTE 0.5% and then re-immunoprecipitated with
anti-Flag (2 IP). The ubiquitin-conjugated proteins were detected by IB. For
GST pull-down and in vitro ubiquitination assays, bacterially expressed GST/
Smurf1 (WT, C699A or truncated mutants) and GST/RhoB were purified using
glutathione sepharose beads in TNTE 0.5% buffer. Free RhoB proteins were
obtained by TEV protease cleavage.
Immunofluorescence assay. Twenty-four hours after transfection, cells grown on
glass coverslips were washed three times in phosphate-buffered saline (PBS), fixed
with 4% paraformaldehyde and permeabilized with 0.25% Triton X-100, then
stained using appropriate primary and fluorescently conjugated secondary anti-
bodies. Flag-tagged Rho proteins were detected using mouse anti-Flag M2 antibody
followed by Alexa Fluor 555 or 647-conjugated donkey anti-mouse secondary
antibody (Invitrogen), and HA-tagged Smurf1 was stained using rat anti-HA
antibody followed by Alexa Fluor 488-conjugated donkey anti-rat secondary
antibody (Invitrogen). Texas Red conjugated Phalloidin was used for F-actin
staining. Images were obtained using a ZEISS LSM 780 confocal microscope with
ZEN 2010 software (Carl Zeiss GmbH, Jena, Germany).
Ultraviolet irradiation and MMS treatment. Cells at 50–70% confluence were
exposed to 80 J m 2 or 10 J m 2 of ultraviolet in Spectrolinker XL-1000 (Spec-
tronics) without culture medium, followed by incubation in the original medium
for determined time. For MMS treatment, cells were treated with 0.5 mM MMS for
determined time and then subjected to IB or flow cytometry.
Apoptosis assay. Cells cultured in 12-well plates were treated with ultraviolet or
MMS, trypsinized and collected. The cells were washed in PBS and fixed with 70%
ethanol overnight, washed and incubated in PBS with 100 units ml 1 RNaseA at
37 C for 30 min, and then stained with 50 mg ml 1 propidium iodide in PBS for
30 min at 37 C in the dark. The percentages of apoptotic cells were calculated by
determining sub-G1 proportion of cells using a Beckman Coulter Epics XL flow
cytometer (Beckman Coulter, Indianapolis, IN, USA).
In vitro kinase assay. HEK293T cells transfected with triple Flag-tagged wild-type
Chk1 or its dominant-negative form Chk1-D130A were pretreated with MMS
(0.5 mM) for 2 h to active the Chk1 before subjected to IP with Flag antibody and
Protein G agarose beads, followed by washing twice with 0.5% TNTE and twice
with kinase reaction buffer (20 mM Tris–HCl pH 7.5, 10 mM MgCl2, 1 mM
dithiothreitol, 25mM ATP). GST/Smurf1 or its mutants purified from bacteria were
incubated with Chk1-bound agarose beads in a total volume of 20 ml of reaction
buffer at 30 C for 30 min before subjected to IB assay.
Subcellular fractionation. Cells were washed twice with ice-cold PBS before lysed
in ice-cold buffer A (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM
DTT, 0.5 mM PMSF, 0.1% NP-40) for 10 min and then centrifuged at 1,200 r.p.m.
for 5 min. The clear cytoplasmic fraction was collected by recentrifuging the
supernatant at 12,000 r.p.m. for 10 min. The nuclear fraction was obtained by
washing the nuclei-containing pellet with cold PBS and resuspended in buffer B
(10 mM HEPES pH 7.9, 20% glycerol, 0.3 M NaCl, 1.5 mM MgCl2, 0.4 mM EDTA,
0.5% NP-40, 1 mM DTT, 0.5 mM PMSF) on a rotator at 4 C for 30 min and then
centrifuged at 12,000 r.p.m. for 10 min.
Quantitative RT–PCR. Total RNAs were extracted from cells or tissue samples
using Trizol reagent (Invitrogen) according to the manufacturer’s instructions.
Reverse transcription was performed with 500 ng of total RNA using PrimeScript
High Fidelity Reverse Transcriptase kit (Takara, Dalian, China). Real-time
amplification of transcripts was performed using a Mastercycler EP gradient S
RealPlex2 (Eppendorf, Hamburg, Germany). The relative changes of gene
expression were determined using the 2DDCt method by normalizing to the
internal control gene GAPDH. The primers for RhoB are 50-GCAGCGACGAGCA
TGTCC-30 (forward) and 50-CCGTTCTGGGAGCCGTAG-30 (reverse); for Smurf1
are 50-AGATCCGTCTGACAGTGTTATG-30 (forward) and 50-CCCATCCACGA
CAATCTTTGC-30 (reverse); and for GAPDH are 50-CATGAGAAGTATGACA
ACAGCCT-30 (forward) and 50-AGTCCTTCCACGATACCAAAGT-30 (reverse).
Statistical analysis. One-way analysis of variance with Tukey’s HSD post test was
used to compare values between different experimental groups using the SPSS
Statistics 19.0 programme. Po0.05 was considered a statistically significant change,
*Po0.05, **Po0.01 and ***Po0.001. All the values were presented as means±s.d.
of at least triplicate experiments.
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